The National Institutes of Health (NIH) campuses host a variety of events that inform, challenge, and unite the biomedical research community. IRP investigators lead or participate in many of these events, and they regularly present their work at scientific conferences at the NIH and around the world. We invite you to learn about (and possibly join us in) some of our upcoming events. Unless otherwise noted, times listed are Eastern Standard Time (EST).
In this presentation, Dr. Scholz will discuss her lab's approach to tackling complex neurodegenerative diseases using modern genomic tools, focusing on Lewy body dementia, a major research area in her lab. She will showcase how we have gained crucial insights into the genetic architecture of this understudied form of dementia by applying genome sequencing and transcriptomic analyses. By integrating multi-omic data and employing cutting-edge analytical methodologies within a systems biology framework, Dr. Scholz's research team has been able to identify risk genes and understand their functional consequences.
The central theme of the Scholz lab’s work on neurodegenerative diseases is to pinpoint molecular information that is particularly relevant for translational applications. This includes highlighting critical pathways commonly affected across the neurodegenerative disease spectrum, identifying opportunities for drug repurposing, and delineating targets for therapeutic development. Her research team's ultimate goal is to translate genomic advances from the lab into clinical practice and trials, thereby improving outcomes for patients with neurodegenerative diseases.
Rare Disease Day® takes place worldwide, typically on or near the last day of February each year, to raise awareness among policymakers and the public about rare diseases and their impact on patients’ lives. This year, NIH's National Center for Advancing Translational Sciences (NCATS) and the US Food and Drug Administration (FDA), both agencies within the Department of Health and Human Services, will sponsor a shared Rare Disease Day event as part of this global observance. FDA-NIH Rare Disease Day aims to provide the rare disease community — patients, caregivers, families, patient advocate groups, researchers, clinicians, health care providers, and trainees/students — with information relevant to their lived experiences, including activities by FDA and NIH that promote research and product development for this underserved population.
The goals of FDA-NIH Rare Disease Day are to:
Demonstrate the NIH and FDA commitment to advancing research and regulatory support for people affected by rare diseases.
Highlight NIH and FDA supported rare diseases research and the development of diagnostics and treatments.
Initiate a mutually beneficial dialogue among the rare diseases community.
Exchange the latest rare diseases information with stakeholders to advance research and therapeutic efforts.
Shine a spotlight on stories told by patients living with a rare disease, their caregivers, and their communities.
FDA-NIH Rare Disease Day seeks to bring together a broad audience including patients, patient advocates, caregivers, health care providers, researchers, trainees, students, industry representatives, and government staff. The event will feature panel discussions, rare diseases stories, in-person exhibitors and scientific posters, and an art exhibition. It is free and open to the public.
The goal of the NCI RNA Biology Initiative is to establish a collaborative environment that promotes the swift exchange of information and expertise regarding the structure, function, and biological significance of RNA. Our objective is to leverage this collective knowledge to advance the development of novel diagnostics and therapies. We actively foster synergistic collaborations among NCI and NIH intramural investigators, as well as between our researchers and the broader RNA community.
The symposium offers the opportunity to learn more about the current status of RNA biology in development and disease, share research, network with leading figures in the field and discuss the use and implications of these advances for clinical applications.
Organized by the NCI RNA Biology Initiativethis symposium will bring together internationally renowned experts in the field of RNA biology, with the focus on:
RNA Processing
RNA Structure and Mechanism
Non-classical RNAs
RNA Therapy
This page was last updated on Friday, October 20, 2023
